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Abstract
Phosphoinositide-3-kinase, class III (PIK3C3) is a member of the phosphoinosite-
3-kinases family, involved in cell signaling, membrane trafﬁcking, and neurode-
velopment. Previous studies have indeed shown an association between PIK3C3
gene variants and both bipolar disorder (BD) and schizophrenia (SZ). Brain-
derived neurotrophic factor (BDNF) is a neurodevelopmental factor, which can
regulate the PI3K signaling pathway. Associations have been reported between
BDNF gene polymorphisms and affective and psychotic disorders. The aim of the
present study was to replicate an association between PIK3C3 and BDNF gene
variants in SZ and BD and a putative epistasis between the two genes. Patients
meeting the DSM-IV criteria of BD and SZ were included in this study (98 BD and
79SZ)aswellas158healthycontrols.BloodDNAwasextractedandgenotypingwas
performed either by the polymerase chain reaction (PCR) technique followed by
enzymatic digestion or by the high-resolution melt (HRM) method. Genotype and
haplotype association was assessed with the UNPHASED statistical program.The
resultsshowedonenominalassociationwithBD(P <0.02)andtworiskhaplotypes
in both SZ (P < 0.001) and BP (P < 0.0005), which survived multiple testing cor-
rection. A modest interaction between a BDNF variant and PI3KC3 polymorphism
was observed (P < 0.04).These preliminary results conﬁrm the genetic association
ofPI3KgenevariantswithbothSZandBD,andsupportthehypothesisthatSZand
BD share a genetic background.
Introduction
Phosphoinositide-3-kinases (PI3K) are a family of enzymes,
which catalyze the addition of a phosphate group to the D3
position of the inositol ring of inositol glycerophospholipids
(Fruman et al. 1998). These proteins are involved in the reg-
ulation of many cellular processes such as proliferation, sur-
vival,andvesicletrafﬁcking(TokerandCantley1997;Falasca
and Maffucci 2009). Three classes have been described ac-
cording to their substrate speciﬁcity and sequence homology
(Vanhaesebroeck and Waterﬁeld 1999). Class I is the most
diversiﬁed with more than 10 catalytic (PIK3C) and regu-
l a t o r y( P I K 3 R )s u b t y p e s .C l a s sI I( P I K 3 C 2 )i sl e s sw e l lu n -
derstood but presents three catalytic isoforms, while class III
(PIK3C3) has only one known subtype (Baker and Koret-
zky 2008). For several years, attention has been exclusively
f o c u s e do nc l a s sIb u tt h e r ei si n c r e a s i n gi n t e r e s ti nc l a s s
III PIK3C, because of its involvement in neurodevelopment
along with its role in autophagy (Baker and Koretzky 2008).
Many neurodevelopmental disorders, such as schizophrenia
(SZ) and autism, arise as a consequence of subtle develop-
mental abnormality (Waite and Eickholt 2010) Moreover,
evidence has supported the existence of a complex interplay
between autophagy, cell proliferation, and cell death dur-
ing neural development in mammals (Cecconi et al. 2007).
In addition, PIK3C3 is located on chromosome 18q12.3,
within the region that maps closely to markers D18S450 and
D18S487, linked to SZ (Williams et al. 1999). The implica-
tion of genetic factors in SZ and bipolar disorder (BD) is
now well established (Craddock et al. 2006). Unsurprisingly,
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associationsbetweenPIK3C3genevariantsinSZandBDhave
been reported (Stopkova et al. 2004; Duan et al. 2005; Saito
etal.2005).ThesestudiessuggestedthatPIK3C3isaputative
candidate gene for SZ, BP, and other neurodevelopmental
diseases.
Brain-derivedneurotrophicfactor(BDNF)isamemberof
the neurotrophin family, also known for its role in neurode-
velopment and cell survival (Huang and Reichardt 2001).
A number of studies have indicated that BDNF is impli-
cated in major depression, mood disorder, and SZ (Duman
2005; Karege et al. 2002; Lu and Martinowitch 2008). Several
studies have subsequently reported some BDNF gene poly-
morphisms associated with mood disorder and psychosis,
particularly the rs6265 (A196G), which replaces a valine by
a methionine residue at position 66 of the protein (Neves–
Pereira et al. 2002; De Luca et al. 2008; Vincze et al. 2008) al-
thoughothersfailedtoreplicatethisassociation(Tochigietal.
2006; Watanabe et al. 2006). Lastly, basic studies have shown
functional interactions between the neurotrophins—BDNF
or neurotrophin-3 (NT-3)—and the phosphoinositol-3 ki-
nase signaling pathway (Kaplan and Cooper 2001; Simpson
et al. 2003; Reichardt 2006).
In this study, we aimed to replicate the association be-
tween the PIK3C3 promoter variant, rs3813065, in both SZ
and BP. This SNP is located in a crucial promoter area that
could control the expression of this gene by POU-containing
transcription factors (Stopkova et al. 2004). Additionally, we
tested two single nucleotide polymorphisms (SNPs) and as-
sessedtheirallelicandhaplotypeassociations:rs8095411and
a dinucleotide repeat (CA) polymorphism also located up-
stream, PIK3C3. In a second time, we assessed the putative
genetic interaction between PIK3C3 and BDNF in both dis-
orders. Finally, we evaluated the overlap hypothesis between
SZ and BD by highlighting genetic variants in common for
these diseases (Craddock et al. 2006). Given the central place
occupied by PI3K and BDNF proteins in signaling networks
andtheircrucialroleinneurodevelopmentandsynapticplas-
ticity,weaimtodeterminewhetherthesetwodisordersshow
similar patterns of genetic association.
Materials and Methods
Subjects
Patients meeting DSM-IV criteria for BD (N = 98) or SZ
(N = 79) and controls (N = 158) were included after they
hadgiveninformedconsentandapprovalofethicscommittee
had been obtained (Table 1). Both BD and SZ patients were
recruitedfromconsecutiveadmissionstothepsychiatricunit
of the Geneva University Hospitals (Geneva, Switzerland).
All patients were descended from at least two generations of
Caucasians, and were interviewed by trained psychiatrists or
psychologists using the French version of the Diagnostic In-
terviewforGeneticStudies(DIGS)ortheMiniInternational
Table 1. Demographic data.
Female Male Mean age ±
(%) (%) SD (yrs) Range
SZ patient (N = 79) 40 (50.6) 39 (49.4) 35 ± 10 20–66
BD patient (N = 98) 50 (46.3) 58 (53.7) 42 ± 11 20–67
Controls (N = 158) 44 (27.8) 114 (72.2) 44 ± 12 17–73
Neuropsychiatric Interview (MINI) (Nurnberger et al. 1994;
Preisigetal.1999).Almostallbipolarpatientswerediagnosed
asBD-I,exceptforsubjectsidentiﬁedasBP-II(98%ofBP-I).
Controls were recruited from blood donors in Geneva Hos-
pitals(Geneva,Switzerland)andmetthecriteriaoftheDIGS
questionnaire for their inclusion. The mean age (±SD) was
35 ± 10, 42 ± 11, and 44 ± 12 years, for SZ, BD, and Con-
trols, respectively. The female composition was 40%, 50%,
and 44%, for SZ, BD, and Controls, respectively.
Genotyping
DNA was extracted from peripheral blood leukocytes by
using of the Nucleon BACC 2 kit (Amersham Biosciences,
GE Healthcare, Glatbrugg, Switzerland). The -432C>T
(rs3813065) was genotyped by restriction digestion with the
enzymeSwaI asdescribedbyStopkovaetal.(2004).Thedin-
ucleotide repeat polymorphism was identiﬁed by the UCSC
genome browser (March 2006). This microsatellite is located
on chromosome 18, between 939, 492, 926–939, 492, 962
bp. This genetic variant was ampliﬁed by polymerase chain
reaction (PCR) on a 96-well plate thermal cycler (Biometra,
Goettingen, Germany).
The following primers were used: 5 -
ACCTTTTCCTACTTCAATTCACA-3  type forward and
5 -TCCTAGAGAAGAGGTATGATGATGG-3  type reverse.
PCR reaction was carried out with 100 ng of genomic DNA
using Hot Star Taq DNA polymerase (Eurobio, Brunschwig,
Basel, Switzerland) in a 25 mL reaction mix containing
1× buffer (Tris-Cl, KCl, (NH4)2SO4,1 5m MM g C l 2;p H
8.7), 0.10 mM dNTPs, 0.03 mM MgCl2,0 . 0 2m Mo fe a c h
primer, 1U Taq polymerase. Ampliﬁcation conditions were
as follows: 95◦Cf o r5m i n ,2 5c y c l e so f9 2 ◦C for 30 sec, 60◦C
for 30 sec, and 72◦C for 30 sec. PCR products were analyzed
by electrophoresis on a 10% polyacrylamide gel at 250 V
for 150 min and visualized with ethidium bromide. Allele
(CA)11 was 88 bp, allele (CA)12 was 90 bp, allele (CA)13 was
92 bp, allele (CA)14 was 94 bp, allele (CA)16 was 98 bp, allele
(CA)17 was 100 bp, and allele (CA)18 was 102 bp.
The SNP rs8095411 was identiﬁed by the En-
sembl data bank and explored by high-resolution melt
(HRM) assay using a Rotor-Gene 6000 instrument
(Corbett Life Science, Australia). Amplicon sequence
was analyzed by the Poland melting software pro-
gram to predict melting behavior (http://www.biophys.uni-
duesseldorf.de/local/POLAND//poland.html).
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The secondary structures were checked by DI-
NAMelt (http://mfold.rna.albany.edu/?q=DINAMelt/Two-
state-folding).
The following primers were used: 5 -
GAGCCTGCAAAAACTCAACA-3  type forward and
5 -AACCCAGCTGTCAGGGAATA-3  type reverse. PCR
reaction was carried out with 100 ng of genomic DNA
using Kappa 2G Robust Hot Start Kit (Kappa Biosystem,
Cape Town, SA) in a 20 μl reaction mix containing 0.2×
buffer 0.2 mM dNTPs, 7.5 mM of each primer, 0.01 mM
Hot Start polymerase, and 1.0 mM Syto9 green ﬂuorescent
intercalating dye (Invitrogen, Eugene, OR). Ampliﬁcation
conditions were as follow: 95◦Cf o r3m i n ,4 5c y c l e so f9 5 ◦C
for 10 sec, 64◦Cf o r3 0s e c ,a n d7 2 ◦C for 10 sec. Methylation
status was identiﬁed by HRM set from 70◦Ct o9 5 ◦C, with
the temperature rising by 0.2◦C per second.
BDNF G196A polymorphism (rs6265) was genotyped by
PCR followed by restriction enzyme digestion. A 133-bp
segment was ampliﬁed by PCR on a 96-well plate ther-
mal cycler (Biometra). The following primers were used: F
5 -GAGGCTTGACATCATTGGCT-3  type forward and 5 -
CGTGTACAAGTCTGCGTCCT-3  type reverse. Target se-
quences were ampliﬁed in a 25-μl reaction mix containing
100 ng of genomic DNA, 1U Taq polymerase (Eurobio), 1.5
mM MgCl2, 200 nM dNTP, and 10 pmol of each primer.
Ampliﬁcation conditions were as follows: 95◦Cf o r5m i n ,
30 cycles of 94◦C for 30 sec, 54◦Cf o r3 0s e c ,a n d7 2 ◦C
for 30 sec. PCR products were then digested overnight with
4 U of Eco72I (MBI Fermentas Inc., Glen Burne, MD). Then
fragmentswereseparatedona10%polyacrylamidegelat250
V and visualized with ethidium bromide. The A-allele undi-
gested product size was 113 bp (A-allele) and the G-allele
showed two fragments of 78 and 35 bp.
Statistics
SNPs with Hardy–Weinberg equilibrium below 0.001 in ei-
ther cases or controls were excluded from analysis.
Haplotype analyses were performed using logistic regres-
sion. All rare haplotypes with frequencies below 1% in both
patients and controls were excluded from analyses. Interac-
tiontestandomnibustests,whichassessedglobaldifferences
in haplotype distribution between SZ and controls, BD and
controls,andSZ+BDandcontrols,wereinitiallyconducted.
If signiﬁcant (below P-value of 0.05), we then used a sliding
window procedure to extract the core haplotype associated
with the diseases.
Since we compared genotypic and allelic distributions
of four polymorphic markers between controls and three
case populations (BP, SZ, and the sum of the two pop-
ulations), a correction for multiple testing was required.
Two approaches were applied to correct for multiple non-
independent comparisons. First, we used the highly conser-
vative Bonferroni correction taking into account the non-
independenceoftests.Weeffectivelytestedfourindependent
polymorphisms, as linkage disequilibrium (LD) between
polymorphisms within the same gene was not so strong.
Two independent tests were considered for the different case
p o p u l a t i o n sa st h es u mo fb o t ho ft h e mw o u l db ec l o s e l y
related to the two case populations taken separately and
because only signiﬁcant results obtained in the whole pop-
ulation would be looked at in the two subpopulations. In
addition, four tests were considered for haplotype analyses
(dinucleotide repeat polymorphism—rs3813065; dinu-
cleotide repeat polymorphism—rs8095411; rs3813065–
rs8095411; and dinucleotide repeat polymorphism—
rs3813065–rs8095411). Finally, an additional test was added
for the interaction term. Therefore, for a Bonferroni correc-
tion on the P-values, we used P = 0.05/(2 × (4 + 4) +
1) = 0.003 as a threshold of signiﬁcance.
We applied the false discovery rate (FDR) to quantify un-
certainty across the multiple hypotheses tested in the three
singlemarkertestsandthemultiplehaplotypetests.TheFDR
q-value was therefore calculated, which denotes the expected
proportionoffalsenegativesamongmultipleﬁndings.Based
on the single marker and haplotype association results, the
q-value for each of these nonindependent tests was calcu-
lated using the step-up procedure (Benjamini and Hochberg
1995). The q-value calculated in this way has been shown to
retaindesirablepropertiesformultiplerelatedtestsingenetic
associationstudiesandcanbeintuitivelyinterpretedinterms
of posterior error probability.
Statistical power to detect associations was estimated us-
ing the Genetic Power Calculator (http://pngu.mgh.harvard.
edu/purcell/gpc/). Thus, we determined that the SZ sample
(N = 79) had 41% power to detect a risk allele with 20% fre-
quency using an additive genotype model at alpha of 0.003.
T h eB Ds a m p l e( N = 109) had 52% power using the same
criteria. The entire sample had 67% power.
Results
Single markers analysis
Three PIK3C3 gene variants (two SNPs: rs3813065 and
rs8095411 and one microsatellite, a CA-repeat) and one
BDNFgenevariant (rs6265)wereanalyzed.Singlemarkeras-
sociationanalysisdetectedasigniﬁcantdifferenceingenotype
andallelicdistributionsofthePIK3C3-432C>T(rs3813065)
between BD patients and controls (P = 0.025, P = 0.028, re-
spectively) (Table 2). This difference was mainly accounted
for by lower frequencies of CT genotype and T-allele in BD
than in controls. However, this association did not hold after
Bonferroni correction for multiple testing. No other asso-
ciation was signiﬁcant either for BDNF or PI3KC3 variants
(Table 2). For the microsatellite variant, genotyping analysis
revealed length polymorphisms in this (CA)n repeat, with n
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Table 2. Allele and genotype distribution in SZ, BD, and control subjects for three polymorphisms of BDNF and PI3KC3 genes.
Population
Statistics (P-value)
Controls BD patient SZ patient
CT vs. CT vs. CT vs.
Variant Genotype n Freq. n Freq. n Freq. BD SZ (BP + SZ)
BDNF AA 9 0.057 3 0.028 4 0.051 0.47 0.75 0.748
rs6264 AG 56 0.354 42 0.385 32 0.405
GG 93 0.589 64 0.587 43 0.544
G 74 0.234 48 0.22 40 0.253 0.71 0.65 0.997
A 242 0.766 170 0.779 118 0.747
PIK3C3 CC 145 0.924 107 0.982 69 0.873 0.025 0.22 0.221
rs3813065 CT 12 0.076 2 0.018 10 0.127
T T 00 00 00
C 302 0.962 216 0.991 148 0.937 0.028 0.24 0.653
T 12 0.038 2 0.009 10 0.063
PIK3C3 AA 112 0.762 86 0.789 57 0.722 0.607 0.51 0.507
rs8095411 AG 35 0.238 23 0.211 22 0.279
G G 00 00 00
A 259 0.881 195 0.895 136 0.861 0.6316 0.54 0.98
G 35 0.119 23 0.106 22 0.139
Freq = frequency; CT = controls; BD = bipolar disorder; SZ = schizophrenia.
P-values that held after Bonferonni correction are in bold face.
rangingfrom11to18.Themostfrequentalleleswere(CA)13
(56.4%), (CA)16 (18.8%), (CA)18 (14.9%), (CA)12 (3.2%),
(CA)17 (3.2%),(CA)14 (2.1%),and(CA)11 (1.4%)(Informa-
tion not displayed), but no association was signiﬁcant either
f o rB Do rS Z .
Haplotype analysis
Omnibus tests comprising the three polymorphic markers,
that is microsatellite, rs3813065, and rs8095411, from the 5 
to the 3  end of the PIK3C3 gene, showed signiﬁcant differ-
ences in the overall haplotype distribution between controls
andSZ(omnibustest:P=0.030,X2=13.96,df=6),controls
and BP (omnibus test: P = 0.017, X2 = 17.02, df = 7), and
controlsandallpatients(SZ+BP)(omnibustest:P =0.016,
X2 = 18.84, df = 8). One three-marker haplotype, (CA)13-
C-G, mainly accounts for these differences. This haplotype
showed higher frequencies in SZ (P = 0.021) and in BP
(P =0.0075)patientsthanincontrols(Table3).Interestingly,
when all patients were pooled together, this risk haplotype
remained signiﬁcant (P = 0.0016) and held after Bonferroni
corrections. To strengthen the power of our analysis and to
highlight at-risk haplotypes, the analysis was then repeated
with haplotypes formed by two-marker combinations ex-
cluding rs3813065. Omnibus tests showed more signiﬁcant
P-values in combined SZ and BP patients compared to con-
trols(omnibustest:P =0.0032,X2 =23.11,df=8).SZonly
and BP only versus controls showed the same tendency (om-
nibus tests: P = 0.0084, X2 = 17.25, df = 6a n dP = 0.017,
X2 =17.09,df=7,respectively).Moreover,evenaftercorrec-
tions for multiple testing, one main haplotype (CA)13-G was
morefrequentinthepooledpopulationofSZandBDpatients
than in controls (P = 5.81 × 10−4). This risk haplotype was
also statistically signiﬁcant in SZ patients (P = 0.0011) and
showed a trend of association in BD patients (P = 0.022).
Asmultiplepositiveﬁndingswereexpectedandfound,the
FDR q-value was calculated to quantify the joint probability
ofmultipleﬁndingsreﬂectingtrueassociationsasopposedto
falsepositives,takingintoaccountallcomparisonsperformed
to test the three hypotheses. The three top associations of the
multiple comparisons (Table 2) were attributed a q-value of
0.09 or less. While, after multiple comparison corrections,
it was not possible to reject all of the null hypotheses at a
conventional level of statistical signiﬁcance, all three of them
were very unlikely to represent false positives.
Interaction analysis between PIK3C3 and
BDNF variants
After the omnibus test, one interaction remained statistically
signiﬁcantbetweenrs6265(BDNF)andrs8095411(PIK3C3)
in SZ compared to controls (omnibus test: P = 0.04637,
X2 = 3.968, df = 1 ) .T h i sr e s u l ti sm a i n l ys u p p o r t e db y
genotype interaction rs6265/ rs8095411 A/G-A/G (16.46%
vs. 6.8%, P = 0.028). This interaction did not survive the
Bonferroni test for multiple corrections.
Discussion
The aim of this case-control study was to assess the potential
role of PIK3C3 geneticvariantsinSZandBDpatientsandits
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Table 3. Haplotype analysis of the PIK3C3 gene in bipolar disorder (BD) and schizophrenia (SZ).
Frequency Statistics (P-value)
Gene variant CT BD SZ BD + SZ CT vs BD CT vs SZ CT vs (BD + SZ)
CA-repeat rs3813065 rs8095411
(CA)13 C G 0.015 0.072 0.072 0.075 0.007 0.02 0.001
(CA)13 G 0.019 0.072 0.112 0.094 0.02 0.001 0.0005
P-values that held after Bonferonni correction are in bold face.; CT = controls; BD = bipolar disorder; SZ = schizophrenia.
possible interaction with a BDNF polymorphism. The anal-
ysis of the single marker yields a difference, albeit modest,
in allele distribution of the rs3813065 (-432C>T) with re-
spect to BD, but not SZ. This result replicates the previous
studyfromStopkovaetal.(2004).Moreover,theminorallele
distribution is similar to that described in previous publi-
cations, which reported that it was very rare in USA and
Czech populations while homozygote was missing in Jew-
ish populations in Israel (Stopkova et al. 2004). It is highly
probable that these authors did not observe any change in
allele distribution either in BD or SZ in USA populations
comparedtocontrols.Thedifferencewasobservedonlywith
Czech and Jewish populations (Stopkova et al. 2004), and
later in African–American populations with SZ (Saito et al.
2005).This suggests that ethnic factors are at play within this
promoter variant.
Interestingly, our study has observed multimarker haplo-
types at risk for BD and SZ. In both diagnostic categories,
the differences from controls were highly signiﬁcant with
am e a no d d sr a t i o( O R )e x c e e d i n gav a l u eo f2 . 5i ne a c h
individual diagnostic category and 3.0 in both diagnostic
categoriescombined.Importantly,P-valuesremainedsignif-
icantafterBonferronicorrection.Consistentwiththereports
above(Stopkovaetal.2004;Saitoetal.2005),thisresultsup-
portsthehypothesisthatPI3KC3genevariantsareimplicated
in the etiology of SZ and BD. This observation is relevant as
many neurobehavioral disorders arise as a consequence of
subtle developmental abnormalities. The genetic alteration
of an important neurobiological factor such as PI3KC could
contribute to these disorders. Previous studies have shown
that the neurobiology of inositol and related lipid kinases
contributes to the pathophysiology of disorders such as SZ
and autism (Waite and Eickholt 2010). Importantly, the fact
that both BD and SZ diagnostics were similarly affected is
in favor of the hypothesis of a shared genetic background
in these diseases. Molecular genetics has recently challenged
the strict dichotomy between BD and SZ, and a number of
important studies have reported alterations in genes or gene
productssharedbythesetwodisorders(Craddocketal.2006;
Shao and Vawter 2008).
Our study also evaluated a putative interaction between
PIK3C3andaBDNFgenevariant(G196A)inthetwopatient
groups. The interaction between these two neurodevelop-
mental factors has been demonstrated in physiologic studies
(Reichardt 2006). BDNF was reported to activate PI3KC and
one of the BDNF–PI3K–AKT signaling pathways plays a piv-
otal role in the long-term maintenance of synaptic plasticity
through translation and transport proteins (Sun et al. 2010).
In contrast to previous reports, our study did not replicate
the association of BDNF variant either in BD or in SZ. This
is probably due to the small size of our population. In BD,
although the allele distribution was nearly the same as in
the previous study (Vincze et al. 2008), the latter emerged
as highly signiﬁcant, because of the greater number of pa-
tients, while the present study felt short statistically (Vincze
et al. 2008). Considering the putative functional role of these
proteins and their cell signaling interaction, we tested for a
potential interactive effect of their polymorphisms in these
disorders. A signiﬁcant association, albeit modest, was ob-
served in this epistasis evaluation.
In conclusion, this study must be considered as a prelimi-
nary investigation and results should be viewed with caution
consideringtheerrorsassociatedwithcase-controlstudiesof
gene candidates. However, given the central place occupied
byPI3KCproteininsignalingnetworksanditscrucialrolein
neurodevelopment, the study deserves to be replicated with
largersamples.Thepossibilitythatgenevariationsareshared
betweenthesetwomajorpsychoses,andtheputativeepistasis
withotherimportantfactors,suchasBDNF,worththorough
investigation.
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